Disitamab vedotin (anti-HER2)
|
Ab183317-5mg
|
ExactAb™, 重组, 已验证, 无叠氮钠, 低内毒素, 无载体, ≥90%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2136633-23-1 |
5mg
|
¥ 6439.9
|
期货,请咨询 |
阿拉丁 |
Disitamab vedotin (anti-HER2)
|
Ab183317-1mg
|
ExactAb™, 重组, 已验证, 无叠氮钠, 低内毒素, 无载体, ≥90%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2136633-23-1 |
1mg
|
¥ 2679.9
|
期货,请咨询 |
阿拉丁 |
Disitamab vedotin (anti-HER2)
|
Ab183317-10mg
|
ExactAb™, 重组, 已验证, 无叠氮钠, 低内毒素, 无载体, ≥90%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2136633-23-1 |
10mg
|
¥ 8729.9
|
期货,请咨询 |
阿拉丁 |
Disitamab vedotin (anti-HER2)
|
Ab183317-100μg
|
ExactAb™, 重组, 已验证, 无叠氮钠, 低内毒素, 无载体, ≥90%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2136633-23-1 |
100μg
|
¥ 539.9
|
期货,请咨询 |
阿拉丁 |
Trastuzumab deruxtecan (anti-ERBB2)
|
Ab183313-5mg
|
ExactAb™, 重组, 已验证, 无叠氮钠, 低内毒素, 无载体, ≥90%(SDS-PAGE&SEC) |
1826843-81-5 |
5mg
|
¥ 16999.9
|
现货 |
阿拉丁 |
Trastuzumab deruxtecan (anti-ERBB2)
|
Ab183313-1mg
|
ExactAb™, 重组, 已验证, 无叠氮钠, 低内毒素, 无载体, ≥90%(SDS-PAGE&SEC) |
1826843-81-5 |
1mg
|
¥ 6079.9
|
现货 |
阿拉丁 |
Trastuzumab deruxtecan (anti-ERBB2)
|
Ab183313-10mg
|
ExactAb™, 重组, 已验证, 无叠氮钠, 低内毒素, 无载体, ≥90%(SDS-PAGE&SEC) |
1826843-81-5 |
10mg
|
¥ 27199.9
|
期货,请咨询 |
阿拉丁 |
Trastuzumab deruxtecan (anti-ERBB2)
|
Ab183313-100μg
|
ExactAb™, 重组, 已验证, 无叠氮钠, 低内毒素, 无载体, ≥90%(SDS-PAGE&SEC) |
1826843-81-5 |
100μg
|
¥ 1219.9
|
现货 |
阿拉丁 |
RG-7652 (anti-PCSK9)
|
Ab183277-10mg
|
Carrier Free, 重组, Low Endotoxin, Azide Free, Validated, ExactAb™, ≥95%(SDS-PAGE&SEC), Lot by Lot |
N/A |
10mg
|
¥ 15999.9
|
期货,请咨询 |
阿拉丁 |
GSK-679586 (anti-IL-13)
|
Ab183228-5mg
|
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
5mg
|
¥ 9999.9
|
期货,请咨询 |
阿拉丁 |
GSK-679586 (anti-IL-13)
|
Ab183228-1mg
|
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
1mg
|
¥ 3319.9
|
期货,请咨询 |
阿拉丁 |
GSK-679586 (anti-IL-13)
|
Ab183228-10mg
|
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
10mg
|
¥ 15999.9
|
期货,请咨询 |
阿拉丁 |
GSK-679586 (anti-IL-13)
|
Ab183228-100μg
|
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
N/A |
100μg
|
¥ 669.9
|
期货,请咨询 |
阿拉丁 |
Sontuzumab (anti-MUC1)
|
Ab183059-5mg
|
无载体, 重组, ExactAb™, 低内毒素, Azide Free, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
372075-37-1 |
5mg
|
¥ 6669.9
|
现货 |
阿拉丁 |
Sontuzumab (anti-MUC1)
|
Ab183059-1mg
|
无载体, 重组, ExactAb™, 低内毒素, Azide Free, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
372075-37-1 |
1mg
|
¥ 2859.9
|
现货 |
阿拉丁 |
Sontuzumab (anti-MUC1)
|
Ab183059-10mg
|
无载体, 重组, ExactAb™, 低内毒素, Azide Free, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
372075-37-1 |
10mg
|
¥ 10689.9
|
期货,请咨询 |
阿拉丁 |
Sontuzumab (anti-MUC1)
|
Ab183059-100μg
|
无载体, 重组, ExactAb™, 低内毒素, Azide Free, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot |
372075-37-1 |
100μg
|
¥ 579.9
|
现货 |
阿拉丁 |
Linvoseltamab (anti-BCMA&CD3)
|
Ab182996-5mg
|
ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥90%(SDS-PAGE&SEC), Lot by Lot |
2408319-25-3 |
5mg
|
¥ 2799.9
|
现货 |
阿拉丁 |
Linvoseltamab (anti-BCMA&CD3)
|
Ab182996-1mg
|
ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥90%(SDS-PAGE&SEC), Lot by Lot |
2408319-25-3 |
1mg
|
¥ 1119.9
|
现货 |
阿拉丁 |
Linvoseltamab (anti-BCMA&CD3)
|
Ab182996-10mg
|
ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥90%(SDS-PAGE&SEC), Lot by Lot |
2408319-25-3 |
10mg
|
¥ 4479.9
|
期货,请咨询 |
阿拉丁 |
Linvoseltamab (anti-BCMA&CD3)
|
Ab182996-100μg
|
ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥90%(SDS-PAGE&SEC), Lot by Lot |
2408319-25-3 |
100μg
|
¥ 229.9
|
现货 |
阿拉丁 |
Ongericimab (anti-PCSK9)
|
Ab182886-10mg
|
ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot |
2145096-91-7 |
10mg
|
¥ 15999.9
|
期货,请咨询 |
阿拉丁 |
Cadonilimab (anti-PD-1&CTLA4)
|
Ab182868-5mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥90%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2394841-59-7 |
5mg
|
¥ 22499.9
|
期货,请咨询 |
阿拉丁 |
Cadonilimab (anti-PD-1&CTLA4)
|
Ab182868-1mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, ≥90%(SDS-PAGE&SEC-HPLC), Lot by Lot |
2394841-59-7 |
1mg
|
¥ 8999.9
|
期货,请咨询 |
阿拉丁 |